Rx Spending Growth Won’t Exceed 8% In Coming Years – Express Scripts
This article was originally published in The Pink Sheet Daily
Growth slowed from double digits in 2014 to 5% in 2015, according to PBM’s annual Drug Trend Report.
You may also be interested in...
Overall unit cost in commercial insurance market was up only 2.5% in 2016 despite 11% list increase for brands, PBM's Drug Trend Report concludes; findings could be counterpoint to public and policymaker concerns with drug pricing.
Program may provide drugs with narrower labels an opportunity to gain preferred formulary status versus entrenched market leaders.
Rate of growth in prescription drug spending is expected to average 6.7% per year from 2016 through 2025, National Health Expenditures report from CMS projects.